Members of the Aslef union are taking industrial action all week in a long-running dispute over pay
Key Insights Using the 2 Stage Free Cash Flow to Equity, Nagarro fair value estimate is €98.31 With €79.70 share price...
Grace Jabbari takes the stand during trial
Marvel actor’s girlfriend Meagan Good is standing by him as trial begins
The K-pop girl band have been negotiating terms with YG Entertainment for months.
Scotland Yard urge the public not to approach Tomas Asmenkas
Simple gestures could be all it takes to alter the colour of your clothes in the future, according to a research team that has developed a colour-changing textile embedded with a tiny camera and making use of artificial intelligence. The technology could help reduce waste by giving people more colour choices for an item of clothing, says Hong Kong-based Laboratory for Artificial Intelligence in Design (AiDLab). Professor Jeanne Tan, who works at Polytechnic University's School of Fashion and Textiles and heads the research team, notes the POFs are made of polymethyl methacrylate which is recyclable and the structure of the textile enables easy separation of POFs from yarns for recycling.
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Dechra Pharmaceuticals(c) Name of the party to the offer with which exempt principal trader is connected:
The rising occurrence of data breaches and cyberattacks, companies are dedicating resources to fortify their cybersecurity measures. System integration plays a crucial role in guaranteeing the smooth incorporation of security solutions into pre-existing systems.New York, Dec. 06, 2023 (GLOBE NEWSWIRE) -- According to Market.us, The Global System Integration Services Market is likely to secure a valuation of USD 472.7 Billion in 2024, with a CAGR of 9.9% during the forecast period. The global mar
Key Insights Significant control over MTN Group by retail investors implies that the general public has more power to...
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeabrdn European Logistics Income plc(c) Name of the party to the offer with which exempt principal trader i
Former prime minister arrived at the inquiry venue three hours early as he faces questions on UK’s late lockdown
ZURICH, December 06, 2023--Copresence to share its significant breakthrough in the balance of quality, efficiency, and cost in the digital avatar generation process at CES 2024.
TOKYO, December 06, 2023--Launch of APO Productivity Databook 2023
New tool automates the process of dilution application accurately and fairly to existing shareholders and protects the fund’s holdings.London, Dec. 06, 2023 (GLOBE NEWSWIRE) -- big xyt, the independent provider of smart data and analytics solutions to the global trading and investment community, today announced the launch of its Portfolio Liquidity Analysis solution. Developed in partnership with investment management firm, Baillie Gifford, it enables buy-side firms to gain an independent view o
Both NBI-1117569 (an M4-preferring agonist) and NBI-1117567 (an M1-preferring agonist) are investigational, oral, muscarinic agonists discovered by Sosei Heptares that may have the potential to treat neurological and neuropsychiatric conditionsNeurocrine Biosciences confirmed a Phase 1 clinical study of NBI-1117569 has started and a Phase 1 study of NBI-1117567 will be initiated in 2024 Tokyo, Japan and Cambridge, UK, 6 December 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), notes it
Forty percent of patients who filled a prescription for Novo Nordisk's Wegovy to treat obesity in 2021 or 2022 were still taking it a year later, more than three times the rate of adherence with older medicines, according to an analysis of medical records and insurance claims data. Only 13% of patients who started taking Contrave from Orexigen Therapeutics and 10% of those who started on Qsymia from Vivus between 2015 and 2022 were still filling their prescriptions a year later, researchers reported on Wednesday in the journal Obesity. The findings involved 1,911 adults, 25% of whom received Wegovy, which belongs to a new class of anti-obesity medications known as GLP-1 agonists originally developed to treat type 2 diabetes.
Iran said Wednesday it sent a capsule into orbit carrying animals as it prepares for human missions in coming years. A report by the official IRNA news agency quoted Telecommunications Minister Isa Zarepour as saying the capsule was launched 130 kilometers (80 miles) into orbit. Zarepour said the launch of the 500-kilogram (1,000-pound) capsule is aimed at sending Iranian astronauts to space in coming years.
Press Release Nokia and Orange set record with 800Gbps transmission trial on 6,600km Dunant live network to prepare for soaring traffic on strategic trans-Atlantic route Trial utilized Nokia 6th-generation super-coherent Photonic Service Engine (PSE-6), signaling readiness of Nokia 1830 family of optical transport platforms to carry next-gen 800GE IP services as global traffic demand soarsField trial validates Orange network capability on transatlantic submarine cable to support 400GE and 800GE
WALTHAM, Mass., December 06, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 15-year virtual power purchasing agreement (VPPA) with international solar developer ib vogt. Thermo Fisher’s 91-megawatt portion of the Serbal solar project will deliver approximately 192,000 megawatt hours of renewable electricity annually. Eurofins Scientific, a global leader in bioanalytical testing, collaborated in the aggregated deal for a 36-megawatt portion